Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancerJian Chen, Peng Zhang|Genome biology|2020Cited by 237
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory studyHaoran Xia, Gening Jiang, Han Zhang et al.|Signal Transduction and Targeted Therapy|2024Cited by 30
A Cyclic Peptide Epitope of an Under-Explored VEGF-B Loop 1 Demonstrated In Vivo Anti-Angiogenic and Anti-Tumor ActivitiesLei Wang, Wang‐Qing Liu, Hongming Fang et al.|Frontiers in Pharmacology|2021Cited by 6